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We previously reported that Nicotiana benthamiana plants transformed with the wild-type 54-kDa region of the pepper
mild mottle tobamovirus, S strain (PMMoV-S), displayed two different resistance responses against PMMoV infection. Some
of the transgenic plants exhibited a complete and highly resistant phenotype while the remaining plants showed a delayed
resistance (Tenllado et al., 1995, Virology 211, 170–183). Here we show that some of the N. benthamiana plants transformed
with a construct expressing a PMMoV-S truncated 54-kDa protein coding sequence also displayed a complete and highly
resistant phenotype similar to that shown by the wild-type 54-kDa transgenic plants. This result indicates that the wild-type,
full-length 54-kDa protein is not required in mediating the complete resistance phenotype against PMMoV. The remaining
truncated 54-kDa transgenic plants were susceptible to PMMoV infection but showed a variable delay in the appearance
of symptoms. Unlike the wild-type 54-kDa transgenic plants, which were initially susceptible to the infection but recovered
later, the truncated 54-kDa transgenic plants never exhibited this delayed resistance phenotype. However, they displayed
a new type of altered symptomatic phenotype. The truncated 54-kDa transgenic lines also exhibited a lower level of
transgenic transcripts compared to the wild-type 54-kDa transgenic lines which could account for the absence of the delayed
resistance phenotype. q 1996 Academic Press, Inc.
The genome of pepper mild mottle tobamovirus, S transgene transcripts did not correlate with the resis-
tance response shown by these plants (20). It has beenstrain (PMMoV-S), has a genetic organization resembling
that of tobacco mosaic virus (TMV) (1). PMMoV-S, like suggested that replicase-mediated resistance in which
there is no direct relationship between resistance andTMV, potentially encodes a 54-kDa protein, the coding
sequence of which is found to be in-frame with the 183- transgene expression is mediated by an RNA-based
mechanism (14). In the present paper, we have investi-kDa protein sequence and shares with it several se-
quence motifs characteristic of viral RNA-dependent RNA gated in whole plants the importance of the PMMoV-S
polymerases (15, 17). Genetically engineered resistance wild-type 54-kDa protein in mediating resistance by pro-
to virus infection has been obtained by transformation of ducing transgenic N. benthamiana plants expressing a
plants with wild-type or modified viral genes encoding truncated 54-kDa protein coding sequence and analyzing
replicase proteins (reviewed in 4). We have shown that these transgenic plants for resistance to PMMoV.
Nicotiana benthamiana plants transformed with the 54- The origin and purification of PMMoV-S, PMMoV-I, and
kDa region of the PMMoV-S display two resistance re- paprika mild mottle virus (PaMMV) are described in (8).
sponses against PMMoV infection (20). Both responses, TMV-U1 was kindly provided by Dr. F. Garcia-Arenal
called complete and delayed resistance phenotypes, (E.T.S.I.A., Madrid, Spain). PMMoV-S RNA was isolated
share some important characteristics with previously re- from purified virus particles by conventional SDS–phenol
ported replicase-mediated resistances (4, 20). The mech- extraction. Cloning of the 54-kDa coding region of
anism(s) of replicase-mediated resistance is not under- PMMoV-S has been described previously (20). During
stood at this time. Studies with protoplasts suggest that this process, the HincII fragment from pU-11 containing
the 54-kDa protein may function as the active molecule the cloned nucleotides 3769–3908 from PMMoV-S was
in replicase-mediated resistance against TMV (3). How- ligated to the HincII-digested p54-1 (nucleotides 3909–
ever, no 54-kDa protein has been detected in either TMV 4185) to create p54-3 (nucleotides 3769–4185). Sequenc-
or PMMoV-S 54-kDa transgenic plants (3, 20). In our ing showed that some other clones examined lacked
PMMoV-S 54-kDa transgenic plants, the levels of the adenosine at position 3909 of the PMMoV-S RNA
sequence (clone p54-2). This single nucleotide deletion
shifted the open reading frame, which caused an in-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 34-1-5627518. E-mail: cibdr89@cc.csic.es. frame translation stop codon 22 codons downstream of
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the deletion site (nucleotides 3974–3976). From p54-2,
cloning procedures similar to those described for the
wild-type 54-kDa gene construct (20) were carried out to
produce p54-7, a clone containing a truncated 54-kDa
coding region of PMMoV-S. The protein encoded by this
modified gene is 18 kDa, both as predicted from the
sequence and as determined by expression of the trun-
cated 54-kDa ORF in Escherichia coli as a C-terminal
fusion to the malE gene in the pMal-c expression vector
(New England Biolabs) (data not shown). The modified
PMMoV-S 54-kDa gene was inserted into the binary
plant transformation vector pGSJ780A as reported for the
wild-type 54-kDa gene (20), resulting in the plasmid
pGSJ780A/54 del. Plasmids were screened by restriction
analysis and partial nucleotide sequence analysis (19).
For comparative purposes, the R1 generations derived
from lines 12 (wild-type 54-kDa transgenic plants) and
44 (vector transgenic plants) (20) were used in this study.
N. benthamiana leaf disks were transformed with Ag-
robacterium tumefaciens LBA 4404 harboring pGSJ780A/
FIG. 1. Northern blot analysis of total RNA extracts from noninocu-54 del (10, 16). Primary transformed plants (R0) were self-
lated, transgenic N. benthamiana plants. (A) Determination of the 54-fertilized and the seeds (R1) were germinated on MS
kDa mRNAs from R1 plants transformed with the wild-type 54-kDa genemedium with 100 mg/liter kanamycin, from which only
(lanes 1 and 2, plant line 12) or with the truncated 54-kDa gene (lanes
unbleached seedlings were transferred to soil. Two 3–5, plant lines 61, 66, and 65). Lane 6 contains RNA extracted from
pGSJ780A-specific primers were used to amplify the a vector-transformed line 44 control plant. Lanes 1–3 were loaded with
20 mg and lanes 4–6 with 30 mg of total RNA. The size of the cucumbertransgene in the primary R0 transgenic plants by PCR
mosaic virus RNAs (in kb) are given to the left. (B) Determination ofas described elsewhere (13, 20). The presence of the
the 54-kDa (top blot) and the Cab-E (bottom blot) mRNAs from line 61transcript containing PMMoV-S 54-kDa sequences was
plants at times equivalent to 0, 15, and 35 dpi (lanes 1–3). PMMoV-S
confirmed by Northern gel hybridization analysis of total 54-kDa or Cab-E transcripts, used to confirm equal loading of the RNA
RNA extracts from R1 plants using specific riboprobes samples, were detected by hybridization with the appropriate 32P-la-
beled RNA probe.(12, 20). Proteins were extracted from truncated 54-kDa
transgenic plants by grinding 50–100 mg leaf tissue in
2 vol Laemmli sample buffer (11) and analyzed by West-
ern blot (21) using the rabbit polyclonal antiserum to the only one-third as long as the wild-type 54-kDa protein.
Successful transformation was assessed on R0 plantsPMMoV-S wild-type 54-kDa protein (20).
R1 seedlings from truncated 54-kDa transgenic and by PCR assay using primers specific to sequences in
the vector transcriptional control regions which flankedcontrol plants were routinely inoculated with 40 mg/ml of
each of the different purified tobamoviruses (PMMoV-S, the cloning site of the viral gene (20) (data not shown).
Northern blot analysis of total RNA extracts from sixPMMoV-I, PaMMV, and TMV-U1) as described (20). When
PMMoV-S RNA was used as inoculum, it was suspended transformant lines (lines 53, 61, 64, 65, 66, and 69)
showed the presence of PMMoV-S 54-kDa-related tran-in plant inoculation buffer (2) and the mixture was inocu-
lated directly onto plants. When plant sap inoculum was scripts of about 1.9 kb, a size comparable with those of
plants expressing the wild-type 54-kDa gene (Fig. 1Aused, it was prepared by grinding infected leaf tissue in
0.02 M sodium phosphate buffer at a ratio of 1 g:10 ml. and data not shown). The amount of PMMoV-S 54-kDa-
specific transcripts was similar in all the transformedAssessment of virus level in transgenic plants was done
by DAS-ELISA according to the procedures previously pGSJ780A/54 del lines examined (not shown). However,
all plants examined from different truncated 54-kDadescribed (6, 20).
In a previous report, the generation and analysis of N. transgenic lines consistently accumulated lower tran-
script levels than wild-type 54-kDa transgenic plants. Thebenthamiana plants expressing the PMMoV-S wild-type
54-kDa gene were described (20). To test whether the viral transcripts from truncated 54-kDa transgenic lines
were barely detected in gel lanes loaded with 20 mg ofcomplete and/or the delayed resistance phenotypes
shown by these plants were related to the expression of RNA (Fig. 1A, lane 3) compared to the transcripts from
wild-type 54-kDa transgenic lines (Fig. 1A, lanes 1 andthe wild-type, full-length 54-kDa protein, N. benthamiana
plants have been transformed with a construct 2), but they were clearly visible in gel lanes loaded with
30 mg of RNA (Fig. 1A, lanes 4 and 5). In several experi-(pGSJ780A/54 del) containing the PMMoV-S truncated
54-kDa gene-coding region capable of yielding a protein ments in which total leaf protein extracts from truncated
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tom delays were detected when compared to the symp-
tom development in susceptible, wild-type 54-kDa as well
as vector transgenic control plants, which were also chal-
lenged in this study. The average level of CP in the sus-
ceptible, truncated 54-kDa transgenic plants from lines
61 and 66 tested at 15 dpi was similar to the level in the
control plants. PMMoV-S CP accumulation in the inocu-
lated leaves of line 61 plants displaying either the com-
plete resistance phenotype or the delay in symptom ex-
pression was significantly reduced compared to that of
the control plants (Fig. 2). Thus, the delay in symptom
appearance shown by the susceptible plants of lines 61
and 66 could be due, at least in part, to the lower level
of virus in the inoculated leaves.
To investigate whether a correlation exits between the
level of 54-kDa-related transcripts and the complete re-
FIG. 2. Analysis of the viral CP accumulation in PMMoV-S-inoculated
sistance phenotype exhibited by some of the truncatedN. benthamiana plants transformed with the truncated 54-kDa gene.
54-kDa transgenic plants, the level of 54-kDa mRNAs inSix truncated 54-kDa transgenic lines (L61, L66, L53, L64, L65, and L69)
and one vector-transformed line (L44) were inoculated with PMMoV-S 10 plants of line 61 was determined before PMMoV-S
at 40 mg/ml. Virus antigen levels in plants were estimated either from inoculation by Northern blot hybridization. The same pro-
the upper leaves at 15 (solid bars) and 35 (open bars) dpi or from the cedures previously used (20) were followed. As de-
inoculated leaves at 9 dpi (lightly shaded bars). Samples were assayed
scribed for the wild-type 54-kDa transgenic plants (20),by DAS-ELISA using alkaline phosphatase-conjugated rabbit anti-
neither positive nor negative correlation existed betweenPMMoV-S antibodies (1:300). Each bar represents the mean value
({SD) of all the plants with positive values in each specific group. the steady-state level of 54-kDa-related transcripts and
ELISA background values represent 0.4 mg of PMMoV-S CP/g tissue. either the complete resistance or the susceptible pheno-
Values at the bottom represent the number of truncated 54-kDa type in the truncated 54-kDa transgenic plants (data not
transgenic plants showing the complete resistance (CR) or susceptible
shown). Unlike the wild-type 54-kDa transgenic plants,(S) phenotypes and the number of vector-transformed plants displaying
which were initially susceptible but exhibited the delayedthe susceptible (S) phenotype as a function of the total number of
inoculated plants. S* indicates the delay in symptom appearance resistance phenotype shown by a recovery phenomenon
shown by the susceptible plants of lines 61 and 66. at 35 dpi (20), the truncated 54-kDa transgenic plants in
no instance displayed this delayed resistance phenotype
through 70 dpi. However, the systemic symptoms in
plants of lines 61 and 66 expressing the truncated 54-54-kDa transgenic plants were checked by Western blot
analysis using antiserum to the wild-type 54-kDa protein, kDa protein gene were altered at the third week postin-
oculation compared to vector or wild-type 54-kDathe truncated 54-kDa protein could not be detected in
any transgenic R1 line (not shown). transgenic plants. This new symptomatic phenotype in-
cluded a characteristic mosaic pattern and curling onIn several independent experiments, four of the six
truncated 54-kDa transgenic lines (lines 53, 64, 65, and newly emerged leaf tissue. In terms of overall disease
syndrome, these truncated 54-kDa transgenic plants69) tested showed no resistance whatsoever against
PMMoV-S infection (40 mg/ml), but instead showed both were protected compared to the control plants which
showed severe stunting and apical growth inhibitiondisease symptoms and PMMoV-S CP levels in systemi-
cally infected leaves similar to those exhibited by the (data not shown). However, the virus concentration in
these truncated 54-kDa plants, as monitored by DAS-vector-alone transgenic, control plants (line 44) (Fig. 2).
The other two transgenic lines (lines 61 and 66), however, ELISA at 35 dpi, was essentially the same as that re-
corded at 15 dpi, before the transgenic plants displayedshowed a percentage of plants displaying a complete
resistance phenotype against PMMoV-S infection, simi- the altered phenotype (Fig. 2). To further investigate the
altered symptomatic phenotype, the upper leaf tissue oflar to that shown by the wild-type 54-kDa transgenic
plants used in these experiments, exhibiting no visible several line 61 plants showing this phenotype at 25 dpi
was homogenized and inoculated onto nontransgenic N.disease symptoms (not shown). The absence or very low
levels of viral CP in these symptomless transgenic plants benthamiana plants. Typical systemic symptoms such as
those observed on PMMoV-S-inoculated, nontransgenicwas confirmed by DAS-ELISA at 15 and 35 days postinoc-
ulation (dpi) (Fig. 2). Most of the remaining transgenic plants were induced in these plants throughout their life
cycles (not shown). Furthermore, the type of symptomsplants from lines 61 and 66 were susceptible but showed
a short delay of 3 to 5 days in the appearance of symp- and time of appearance (7 dpi) were indistinguishable
between the two groups of plants, and in no instancetoms (not shown), although few individual plants did not
display systemic symptoms for up to 21 dpi. These symp- did the plants display the altered symptomatic phenotype
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through 70 dpi. Therefore, prolonged infection of the trun- detected by both symptom expression and DAS-ELISA
(data no shown). These results indicate that the viralcated 54-kDa transgenic plants with PMMoV-S appar-
ently does not result in the generation of new virus vari- resistance established in both types of transgenic plants
exhibiting the complete resistance phenotype is a highlyants, suggesting an involvement of the transgene prod-
uct, RNA or protein, in the altered symptomatic virus-specific state.
Our results have demonstrated that the preestab-phenotype. In order to evaluate possible mechanisms
involved in the establishment of this phenotype, the lev- lished, complete resistance phenotype against PMMoV
in plants transformed with the wild-type 54-kDa gene ofels of truncated 54-kDa transcripts were monitored by
Northern blot hybridization using upper leaf tissue from PMMoV-S is also expressed in plants transformed with
a modified and truncated PMMoV-S 54-kDa gene. Fromnoninoculated line 61 plants at different times of their
life cycles. Similar transgene expression was always this result, we infer that the wild-type, full-length 54-kDa
protein is not required in mediating complete resistancefound in the noninoculated plants at the different times
tested, which were equivalent to 0, 15, and 35 dpi (Fig. to PMMoV. This inference is based on the fact that the
complete resistance found in both the wild-type and1B). Thus, the possibility that any change in the truncated
54-kDa mRNA accumulation level, occurring during the the truncated 54-kDa transgenic plants exhibits the
same characteristics of protection against PMMoVnormal development of the plant, could be responsible
for the altered symptomatic phenotype seems unlikely, infection. Both the lack of disease symptoms and the
very low titers (or even complete absence) of viral CPas the level of transcript accumulation in the noninocu-
lated plants remains unchanged throughout the plant life observed in the two lines transformed with the
truncated 54-kDa gene resemble those observed in thecycle.
The PMMoV resistance in wild-type 54-kDa transgenic complete resistance phenotype exhibited by wild-type
54-kDa transgenic plants. In addition, the complete resis-plants was previously reported to be highly virus strain-
specific and effective against inoculation with PMMoV- tance phenotype exhibited by both groups of transgenic
plants shares important similarities with some previouslyS RNA (20). We therefore tested both features in plants
transformed with the truncated 54-kDa gene by challeng- reported replicase-mediated resistances, which are
thought to be distinctive features of an RNA-based mech-ing some of these transgenic plant lines against PMMoV-
S RNA (10 mg/ml) or against different PMMoV-S-related, anism for this type of resistance (14): (a) The resistance
is effective against both virus and viral RNA; (b) for apepper resistance-breaking tobamoviruses, such as
PMMoV-I and PaMMV, and against TMV-U1 (Table 1). given transgene, the resistance is not correlated with the
transgene RNA level in the different transgenic lines; andAs in previous results with PMMoV-S virions, a similar
proportion of truncated 54-kDa plants from lines 61 and (c) the resistance is highly virus strain-specific.
Previous studies on replicase-mediated resistance66 also exhibited the complete resistance phenotype
upon infection with either PMMoV-I or PMMoV-S RNA, against TMV seem to suggest a role for the 54-kDa pro-
tein itself in mediating the resistance to the virus (3). Thiswhile the remaining plants showed a variable delay in the
appearance of symptoms, lately displaying the altered evidence is based on a transient-expression assay in
protoplasts. However, attempts to detect the 54-kDa pro-symptomatic phenotype at similar times postinoculation
as with PMMoV-S. Thus, the complete resistance in tein in the transgenic plants have not been successful. In
our case, a solely protein-mediated complete resistancethese truncated 54-kDa plants is equally effective against
either PMMoV-S virion or RNA. As expected, no resis- does not seem to be consistent with the same type of
resistance being produced by both the wild-type andtance to either PaMMV or TMV-U1 was found in these
two lines, in agreement with the specific spectrum of the truncated forms of the PMMoV-S 54-kDa transgene.
Indeed, the sequence for the PMMoV-S truncated 54-resistance operating in replicase-mediated strategies as
well as with the previously reported results in wild-type kDa protein, which encodes the N-terminal one-third of
the wild-type protein, does not include any of the four54-kDa plants. Furthermore, PaMMV- and TMV-U1-inocu-
lated plants did not show either the delay in symptom amino acid sequence domains which are highly con-
served among RNA-dependent RNA polymerases (17).appearance or the altered symptomatic phenotype. Virus
accumulation on inoculated and upper leaf tissue as de- Therefore, it seems likely that the complete resistance
phenotype in both truncated and wild-type 54-kDatermined by DAS-ELISA was correlated with visual symp-
toms in all the different transgenic plants tested (Table transgenic plants is only or mainly mediated by the RNA
product of the transgene. Both the wild-type and the trun-1). In order to compare in more detail the complete resis-
tance phenotype exhibited by both the wild-type and the cated 54-kDa gene constructs are expected to be capa-
ble of generating transcripts of the same length and nu-truncated 54-kDa transgenic plants, TMV-U1 (40 mg/ml)
was used to challenge nine plants each of lines 12 and cleotide sequence with only one nucleotide difference
between them. It is conceivable that both transgene61, previously found to display the complete resistance
phenotype to PMMoV-S. All these plants were shown to products, the wild-type and the truncated 54-kDa pro-
teins, behave as nonfunctional, defective versions of thebe susceptible to TMV-U1 infection within 7 days, as
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TABLE 1
Assessment of Resistance to PMMoV-S RNA and PMMoV-S-Related Viruses in Truncated 54-kDa Transgenic N. benthamiana Plants
Inoculatedb leaves Upper b leaves
Inoculum Line Phenotypea 9 dpi 15 dpi 35 dpi
PMMoV-I (40 mg/ml) 61 CR (3/9) 0.4 6.5 2.2
S* (6/9) 3.6 6650 4600
69 S (7/7) ND 6040 5300
44 S (6/6) 290 5480 7200
TMV-U1 (40 mg/ml) 66 S (10/10) ND 7900 —
44 S (5/5) ND 10,160 —
PaMMV (40 mg/ml) 66 S (10/10) ND 2140 ND
44 S (5/5) ND 4930 ND
PMMoV-S RNA (10 mg/ml) 61 CR (2/10) 0.4 0.7 1.8
S* 600 (3/10) 4422 (6/10) 7255 (8/10)
0.4 (5/10) 3.2 (2/10)
66 CR (6/10) 1.5 0.4 1.2
S* 466 (3/10) 6395 (4/10) 8530 (4/10)
0.4 (1/10)
44 S (8/8) 1480 5600 6140
a Data in parentheses represent the number of truncated 54-kDa transgenic plants (lines 61, 66, and 69) showing the complete resistance (CR)
or the susceptible (S) phenotypes and the number of vector transgenic plants (line 44) displaying the susceptible (S) phenotype to PMMoV-I, TMV-
U1, or PaMMV infections as a function of the total number of inoculated plants. S* indicates the delay in symptom appearance shown by the
susceptible plants of lines 61 and 66.
b Values correspond to virus antigen levels expressed as micrograms of viral CP per gram of fresh weight leaf tissue at 9 dpi (inoculated leaves)
or at 15 and 35 dpi (upper leaves) as determined by DAS-ELISA. PMMoV-S, PaMMV, and TMV-U1-specific alkaline phosphatase-conjugated IgGs
were used at 1:300 (PMMoV-S) or 1:600 (PaMMV and TMV) dilution. PMMoV-S antiserum cross-reacted with PMMoV-I antigen. ELISA interpolation
data represent the mean value of all the plants with positive values in each specific group. ELISA background values represent0.4 mg of PMMoV-S
CP/g tissue. All plants inoculated with TMV-U1 died within 20–25 dpi. ND, not determined.
183-kDa replicase protein, working as dominant negative kDa transgenic lines accumulated transgenic transcripts
at a lower level than wild-type 54-kDa transgenic lines,mutants for the disruption of gene function (9). Nonethe-
less, the evidence discussed above points toward a role in spite of the fact that both transgenes are expressed
under the same transcriptional regulatory regions. Thus,of the 54-kDa-related transcripts in the complete resis-
tance observed, although a dual RNA–protein-mediated if recovery phenomena are RNA-mediated as suggested
by other authors in reference to transgenic plants ex-mechanism cannot be completely ruled out.
In principle, the results of this study seem to indicate pressing potyvirus CP sequences (7), this low level of
mRNA accumulation may account for the absence of thethat the wild-type 54-kDa protein could be involved in
mediating the delayed resistance phenotype exhibited delayed resistance phenotype observed in our truncated
54-kDa transgenic plants.by a percentage of wild-type 54-kDa transgenic plants
(20). In fact, plants expressing the truncated 54-kDa gene
construct never exhibited the recovery phenotype as re- ACKNOWLEDGMENTS
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